{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T18:27:20Z","timestamp":1793125640653,"version":"4.5.0"},"reference-count":38,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T00:00:00Z","timestamp":1750204800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Public Health"],"abstract":"<jats:p>Human papillomavirus (HPV) is the most common sexually transmitted infection in men and women and is responsible for a substantial burden of disease worldwide. Although HPV-related disease burden is high in women due to cervical related disease and cancer, men are directly affected by HPV. According to the World Health Organization (WHO), one in three men has a prevalent HPV infection worldwide. Currently, there is a lack of data regarding the epidemiology and healthcare resource utilization (HCRU) of HPV-associated cancers among Costa Rican men. This study aimed to describe the epidemiological characteristics of HPV-associated male cancer and disease and the HCRU in Costa Rica. HPV-related cancers in men were assessed through retrospective database study for epidemiology and Delphi panel with five experts for HCRU. A total of 1,340 men with penile, anal, and head and neck cancers between 2012 and 2016 were identified in the database, with a mean age of 63.6 years. Anal cancer accounted for 48% of cases, followed by head and neck 44%, and penile cancer 11%. The cumulative rate of HPV-associated cancer in men per 100,000 population increased from 8.6 in 2012 to 55.5 in 2016. According to 4\/5 panelists, resources for the disease management were also scarce. Panelists agreed that the cost for HPV management within their institution was 0.6\u201340,000 USD. Despite the increasing incidence e of HPV-related cancer in men, HPV prevention in men continues to be an under-served issue in public policy that could result in substantial economic and clinical burden. National health authorities should promote strategies to prevent HPV infections and associated diseases among Costa Rican men.<\/jats:p>","DOI":"10.3389\/fpubh.2025.1487256","type":"journal-article","created":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T05:48:59Z","timestamp":1750225739000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["The growing impact of human papilloma virus (HPV)-associated cancers in men in Costa Rica: epidemiological and economic burden"],"prefix":"10.3389","volume":"13","author":[{"given":"Sebastian","family":"Ospina-Henao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Brenes-Castillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcel","family":"Marcano-Lozada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Alejandra","family":"Betancur-D\u00edaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Medina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helena","family":"Brenes-Chacon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria L.","family":"Avila-Aguero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,6,18]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.3390\/v14081797","article-title":"Regulation of the innate immune response during the human papillomavirus life cycle","volume":"14","author":"Moody","year":"2022","journal-title":"Viruses."},{"key":"B2","first-page":"80","article-title":"Review of HPV-related diseases and cancers","volume":"40","author":"Brianti","year":"2017","journal-title":"New Microbiol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"888","DOI":"10.3201\/eid1406.0706162","article-title":"Transmission of human papillomavirus in heterosexual couples","volume":"14","author":"Hernandez","year":"2008","journal-title":"Emerg Infect Dis."},{"key":"B4","doi-asserted-by":"publisher","first-page":"864","DOI":"10.20892\/j.issn.2095-3941.2020.0370","article-title":"Biological and clinical aspects of HPV-related cancers","volume":"17","author":"Szymonowicz","year":"2020","journal-title":"Cancer Biol Med."},{"key":"B5","doi-asserted-by":"publisher","first-page":"3235","DOI":"10.1200\/JCO.2015.61.6995","article-title":"Epidemiology of human papillomavirus-positive head and neck squamous cell carcinoma","volume":"33","author":"Gillison","year":"2015","journal-title":"J Clin Oncol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"e222530","DOI":"10.1001\/jamanetworkopen.2022.2530","article-title":"Trends in human papillomavirus-associated cancers, demographic characteristics, and vaccinations in the US, 2001-2017","volume":"5","author":"Liao","year":"2022","journal-title":"JAMA Netw Open."},{"key":"B7","doi-asserted-by":"publisher","first-page":"6016","DOI":"10.1016\/j.vaccine.2012.07.056","article-title":"Estimates of the annual direct medical costs of the prevention and treatment of disease associated with human papillomavirus in the United States","volume":"30","author":"Chesson","year":"2012","journal-title":"Vaccine."},{"key":"B8","doi-asserted-by":"publisher","first-page":"4633","DOI":"10.1016\/j.vaccine.2018.06.046","article-title":"The economic burden of human papillomavirus infection-associated diseases in the Republic of Korea, 2002\u20132015","volume":"36","author":"Ki","year":"2018","journal-title":"Vaccine."},{"key":"B9","first-page":"691","article-title":"Incidencia del virus de papiloma humano en hombres","volume":"612","author":"Mora","year":"2014","journal-title":"Revista Medica de Costa Rica y Centroamerica LXXI."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1067299","DOI":"10.3389\/fpubh.2023.1067299","article-title":"Gender neutral HPV vaccination programs: reconsidering policies to expand cancer prevention globally","volume":"11","author":"Dykens","year":"2023","journal-title":"Front Public Health."},{"key":"B11","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s13027-021-00403-1","article-title":"Healthcare resource utilization and costs associated with anogenital warts in morocco","volume":"16","author":"Berrada","year":"2021","journal-title":"Infect Agent Cancer."},{"key":"B12","doi-asserted-by":"publisher","first-page":"e20476","DOI":"10.1371\/journal.pone.0020476","article-title":"Using and reporting the delphi method for selecting healthcare quality indicators: a systematic review","volume":"6","author":"Boulkedid","year":"2011","journal-title":"PLoS ONE."},{"key":"B13","unstructured":"Bruni LA\n              G\n            \n            \n              Serrano\n              B\n            \n            \n              Mena\n              M\n            \n            \n              Collado\n              JJ\n            \n            \n              Gomez\n              D\n            \n            \n              Munoz\n              J\n            \n          \n          Human Papillomavirus and Related Diseases Report\n          \n          2023"},{"key":"B14","unstructured":"The World Bank\n          \n          \n          \n          2023"},{"key":"B15","doi-asserted-by":"publisher","first-page":"4294","DOI":"10.1200\/JCO.2011.36.4596","article-title":"Human papillomavirus and rising oropharyngeal cancer incidence in the United States","volume":"29","author":"Chaturvedi","year":"2011","journal-title":"J Clin Oncol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"e1345","DOI":"10.1016\/S2214-109X(23)00305-4","article-title":"Global and regional estimates of genital human papillomavirus prevalence among men: a systematic review and meta-analysis","volume":"11","author":"Bruni","year":"2023","journal-title":"Lancet Glob Health."},{"key":"B17","first-page":"232","article-title":"Burden of human papillomavirus infection and related comorbidities in men: implications for research, disease prevention and health promotion among hispanic men","volume":"29","author":"Colon-Lopez","year":"2010","journal-title":"P R Health Sci J."},{"key":"B18","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1002\/ijc.30716","article-title":"Worldwide burden of cancer attributable to HPV by site, country and HPV type","volume":"141","author":"de Martel","year":"2017","journal-title":"Int J Cancer."},{"key":"B19","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1016\/j.canep.2013.09.015","article-title":"Squamous anal cancer: patient characteristics and HPV type distribution","volume":"37","author":"Ouhoummane","year":"2013","journal-title":"Cancer Epidemiol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"645","DOI":"10.21149\/8454","article-title":"Prevalence and incidence of anal human papillomavirus infection in Mexican men: Need for universal prevention policies","volume":"60","author":"Posso","year":"2018","journal-title":"Salud Publica Mex"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1111\/andr.13817","article-title":"Prevalence of HPV infection in the general population of young and adult males in Italy","author":"Grande","year":"2024","journal-title":"Andrology"},{"key":"B22","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1053\/j.semdp.2011.09.001","article-title":"The role of human papillomavirus infection in the pathogenesis of penile squamous cell carcinomas","volume":"29","author":"Chaux","year":"2012","journal-title":"Semin Diagn Pathol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1111\/j.1463-1318.2005.00774.x","article-title":"Analysis of adenocarcinoma of the colon and anal: detection of human papillomavirus (HPV) DNA by polymerase chain reaction","volume":"7","author":"Perez","year":"2005","journal-title":"Coloanal Dis."},{"key":"B24","doi-asserted-by":"publisher","first-page":"2123","DOI":"10.1007\/s10552-010-9631-5","article-title":"Association between human papillomavirus and adenocarcinoma of anal and recto-sigmoid junction: a cohort study of 10,612 women in Taiwan","volume":"21","author":"Chuang","year":"2010","journal-title":"Cancer Causes Control."},{"key":"B25","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1016\/j.aogh.2014.09.014","article-title":"Screening for cancer in low- and middle-income countries","volume":"80","author":"Sankaranarayanan","year":"2014","journal-title":"Ann Glob Health."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1077651","DOI":"10.3389\/fcimb.2022.1077651","article-title":"Prevention and treatment of human papillomavirus in men benefits both men and women","volume":"12","author":"Zou","year":"2022","journal-title":"Front Cell Infect Microbiol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1158\/1940-6207.CAPR-11-0542","article-title":"Reducing HPV-associated cancer globally","volume":"5","author":"Lowy","year":"2012","journal-title":"Cancer Prev Res."},{"key":"B28","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1186\/s12885-019-5596-2","article-title":"The healthcare costs of treating human papillomavirus-related cancers in Norway","volume":"19","author":"Hylin","year":"2019","journal-title":"BMC Cancer"},{"key":"B29","doi-asserted-by":"publisher","first-page":"e0202564","DOI":"10.1371\/journal.pone.0202564","article-title":"Epidemiological and economic burden of potentially HPV-related cancers in France","volume":"13","author":"Abramowitz","year":"2018","journal-title":"PLoS ONE."},{"key":"B30","doi-asserted-by":"publisher","first-page":"e0179520","DOI":"10.1371\/journal.pone.0179520","article-title":"The economic burden of human papillomavirus-related precancers and cancers in Sweden","volume":"12","author":"\u00d6stensson","year":"2017","journal-title":"PLoS ONE."},{"key":"B31","doi-asserted-by":"publisher","first-page":"e0220534","DOI":"10.1371\/journal.pone.0220534","article-title":"Societal cost of oropharyngeal cancer by human papillomavirus status, cancer stage, and subsite","volume":"14","author":"Silfverschi\u00f6ld","year":"2019","journal-title":"PLoS ONE."},{"key":"B32","doi-asserted-by":"publisher","first-page":"5245","DOI":"10.1016\/j.vaccine.2011.05.018","article-title":"Economic burden of HPV-related cancers in France","volume":"29","author":"Borget","year":"2011","journal-title":"Vaccine."},{"key":"B33","doi-asserted-by":"publisher","first-page":"763","DOI":"10.3111\/13696998.2013.793691","article-title":"Economic burden of non-cervical cancers attributable to human papillomavirus: a European scoping review","volume":"16","author":"Preaud","year":"2013","journal-title":"J Med Econ."},{"key":"B34","unstructured":"World Health Organization\n          \n          \n          2023"},{"key":"B35","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: globocan estimates of incidence and mortality worldwide for 36 cancers in 185 Countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin."},{"key":"B36","doi-asserted-by":"publisher","first-page":"e180","DOI":"10.1016\/S2214-109X(19)30488-7","article-title":"Global burden of cancer attributable to infections in 2018: a worldwide incidence analysis","volume":"8","author":"de Martel","year":"2020","journal-title":"Lancet Glob Health."},{"key":"B37","doi-asserted-by":"publisher","first-page":"S15","DOI":"10.1016\/j.ygyno.2010.01.026","article-title":"Epidemiology and pathology of HPV disease in males","volume":"117","author":"Giuliano","year":"2010","journal-title":"Gynecol Oncol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"pky045","DOI":"10.1093\/jncics\/pky045","article-title":"Burden of human papillomavirus (HPV)-related cancers attributable to HPVs 6\/11\/16\/18\/31\/33\/45\/52 and 58","volume":"2","author":"de Sanjose","year":"2018","journal-title":"JNCI Cancer Spectr."}],"container-title":["Frontiers in Public Health"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2025.1487256\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T05:49:02Z","timestamp":1750225742000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2025.1487256\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,18]]},"references-count":38,"alternative-id":["10.3389\/fpubh.2025.1487256"],"URL":"https:\/\/doi.org\/10.3389\/fpubh.2025.1487256","relation":{},"ISSN":["2296-2565"],"issn-type":[{"value":"2296-2565","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,18]]},"article-number":"1487256"}}